The iCTS Advantage
Accelerate your clinical development pipeline with our globally integrated site network, proprietary patient database, and unified technology platform.
Why partner with iCTS?
We own and operate our entire site network, meaning no third-party delays, standardized training, and a single point of accountability for your trial.
Patient Identification & Engagement
Leveraging our proprietary database of 20M+ profiles and advanced AI targeting, we consistently exceed enrollment targets up to 30% faster than industry averages.
Global Site Network
Access 250+ highly standardized, fully owned clinical research sites across North America, Europe, and APAC, ensuring consistent protocols globally.
Data Quality & Oversight
Our unified technology stack provides real-time oversight, ensuring 99.8% data accuracy and reducing source data verification timelines.
Flexible & Scalable Solutions
From traditional site-based models to fully decentralized home trials, we adapt our operational framework to suit your unique protocol requirements.
Accelerating Phase III Asthma Enrollment by 45%
See how our hybrid approach utilizing centralized screening and 12 dedicated sites delivered a fully enrolled study 4 months ahead of schedule.
